Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease

Cornea

Volumn 26, Issue 10, 2007, Pages 1195-1199

  Jacobs, Deborah S ^a,b   Rosenthal, Perry ^a,b  

^a Boston Foundation for Sight   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Contact lens; Dry eye syndrome; Graftversus host disease; Scleral lens

Indexed keywords

ADULT; AGED; ARTICLE; CAR DRIVING; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DRY EYE; FEMALE; HUMAN; LENS IMPLANT; MALE; MEDICAL RECORD REVIEW; PAIN; PHOTOPHOBIA; PRIORITY JOURNAL; QUALITY OF LIFE; READING; RETROSPECTIVE STUDY; SCLERAL LENS;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; CHRONIC DISEASE; CONTACT LENSES; DRY EYE SYNDROMES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PAIN; PHOTOPHOBIA; PROSTHESES AND IMPLANTS; PROSTHESIS FITTING; QUALITY OF LIFE; SCLERA;

EID: 36549022200     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318155743d     Document Type: Article

References (21)

1. Balaram M, Rashid S, Dana R. Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul Surf. 2005;3:203-211.
2. Jabs DA, Wingard J, Green WR, et al. The eye in bone marrow transplantation. Arch Ophthalmol. 1989;107:1343-1348.
3. Ogawa Y, Okamoto S, Wakui M, et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol. 1999;83:1125-1130.
4. Rosenthal P, Croteau A. Fluid-ventilated gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens. 2005;31:130-135.
5. Rosenthal P, Cotter JM, Baum J. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permaeable scleral contact lens. Am J Ophthalmol. 2000;130:33-41.
6. Kok JHC, Visser R. Treatment of ocular surface disorders and dry eyes with high gas-permeable scleral lenses. Cornea. 1992;11:518-522.
7. Tan DTH, Pullum KW, Buckley RJ. Medical application of scleral contact lenses: 1. A retrospective analysis of 343 cases. Cornea. 1995;14:121-129.
8. Tan DTH, Pullum KW, Buckley RJ. Medical application of scleral contact lenses: 2. Gas-permeable scleral contact lenses. Cornea. 1995;14:130-137.
9. Segal O, Barkana Y, Hourovitz D, et al. Scleral contact lenses may help where other modalities fail. Cornea. 2003;22:308-310.
10. Pullum KW, Whiting MA, Buckley RJ. Scleral contact lenses, the expanding role. Cornea. 2005;24:269-277.
11. Pullum K, Buckley R. Therapeutic and ocular surface indications for scleral contact lenses. Ocul Surf. 2007;5:40-48.
12. McDermott ML, Chandler JW. Therpeutic uses of contact lenses. Surv Ophthalmol. 1989;33:381-394.
13. Donnenfeld ED, Selkin BA, Perry HD, et al. Controlled evaluation of a bandage contact lens and a topical nonsteroidal anti-inflammatory drug in treating traumatic corneal abrasions. Ophthalmology. 1995;102:979-984.
14. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762-770.
15. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Vision Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
16. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584-589.
17. Gipson IK, Argüeso P, Beuerman R, et al. Research in dry eye: report of the Research Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:179-193.
18. Luo L, Li DQ, Corrales RM, et al. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005;31:186-193.
19. Neiderkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T cell-mediated Sjogren's syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006;176:3950-3957.
20. Barabino S, Shen LL, Chen L, et al. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 2005;46:2766-2771.
21. DePaiva CS, Corrales RM, Villareal AL, et al. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci. 2006;47:2847-2856.